Market revenue in 2023 | USD 289.0 million |
Market revenue in 2030 | USD 368.1 million |
Growth rate | 3.5% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche Holding AG ADR, Qiagen NV, Siemens Healthineers AG ADR, Becton Dickinson & Co, Illumina Inc, Epigenomics AG, Koninklijke Philips NV, FUJIFILM Holdings Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liver cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 58.96% in 2023. Horizon Databook has segmented the Canada liver cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in prevalence of liver cancer in the country is anticipated to impact the market growth significantly in the near future. The University of Toronto states that deaths caused due to liver cancer have been increasing drastically in the past 25 years. In the year 1993, an estimated 1.6 Canadian women were diagnosed with liver cancer which doubled in the year 2017.
As these diseases are not treated on time, they cause cirrhosis and liver cancer. In 2020 there were over 230,000 individuals diagnosed with hepatitis B and an estimated 250,000 individuals diagnosed with hepatitis C. In addition, the rising obesity epidemic is another factor causing liver cancer in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada liver cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada liver cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account